Latest: Achieve accuracy and reliability in cell counting
Latest: Abbott receives FDA approval for rapid concussion test
Latest: Bioanalytic breakthroughs redefine drug development
Latest: How to navigate the lab digitalization journey
Latest: SelectScience Analytical Science Summit 2024 – Taking place today!
Latest: Streamline food safety analysis through automation
Latest: Malvern Panalytical launches Revontium at Analytica 2024
Overcome anti-doping analysis obstacles
Achieve accuracy and reliability in cell counting
Kuraray launches new PVA hydrogel microcarriers for cell cultures
ELRIG UK and SRG announce partnership to advance life science professionals
Analytical measurements supporting cellular therapies
Evolution in gene therapy vector analysis
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
Preparation of bacterial samples for sequencing
Eurofins integrated flow cytometry
Automated QuEChERS extraction and extract clean-up
Analysis of highly polar pesticides
How to Buy Cell Counting Equipment
Microplate Readers
How to Buy Microscopy Equipment
How to Buy Water Purification Technology
How to Buy Clinical Laboratory Automation Technology
Biophysical Characterization Technology
ABRF 2024 Annual meeting
21 Apr 24 - 24 Apr 24
Immuno-Oncology Summit...
23 Apr 24 - 25 Apr 24
ECCMID 2024 - 34th European...
27 Apr 24 - 30 Apr 24
Immunology2024
03 May 24 - 07 May 24
CYTO 2024
04 May 24 - 08 May 24
MS β-glucuronidase is a prebuffered, bench-stable, and automation-ready hydrolysis mix for urine drug testing workflows. Discover how to leverage its reduced hands-on time and improved stability. Read more...
Rapid drug screening for safer roads is in your hands Read more...
Read more...
IMCSzyme ® is a genetically modified beta-glucuronidase used to detect a wide range of drugs by hydrolyzing glucuronides in biological fluids. Read more...
Convenient specimen collection combined with accurate laboratory analysis. Read more...